Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
696 items
Woman crossing a stream in the woods

How the brain interprets motion while in motion

June 13, 2022

New findings about how the brain interprets sensory information may have applications for treating brain disorders and designing artificial intelligence.
Drawing of brain inside a color wheel

Neuroscientists Find New Factors Behind Better Vision

June 13, 2022

The size of our primary visual cortex and the amount of brain tissue we have dedicated to processing visual information can predict how well we can see, a new study shows.
Traffic

New research examines vision screenings in older drivers

June 9, 2022

New research from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine is shining a light on whether vision screenings for older drivers identify those who are likely to have motor vehicle collisions in the next few years.
Images of a patient eye with new TIMP3 maculopathy

NIH researchers discover new genetic eye disease

June 8, 2022

Researchers from the National Eye Institute (NEI) have identified a new disease that affects the macula, a small part of the light-sensing retina needed for sharp, central vision.
Cells of the fruit fly brain.

Buck researchers uncover intriguing connection between diet, eye health and lifespan

June 7, 2022

Researchers from the Buck Institute have demonstrated for the first time a link between diet, circadian rhythms, eye health and lifespan.

NIH study confirms benefit of supplements for slowing age-related macular degeneration

June 2, 2022

The AREDS2 formula not only reduces risk of lung cancer due to beta-carotene, but is also more effective at reducing risk of AMD progression, compared to the original formula.
Comparison of two retinal images.

Gene therapy for rare eye disease safe but lacks efficacy in early trial

May 31, 2022

A 28-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy (LHON) found no significant safety concerns; however, treatment failed to improve or slow vision loss, with even the highest dose.

Noninvasive technique collects sufficient tear fluid to look for biomarkers of health and disease

May 27, 2022

Scientists from Augusta University have fine-tuned a non-invasive and efficient way to evaluate the tear film for clues about wellness and disease.

Life after death for the human eye

May 11, 2022

Scientists have revived light-sensing neuron cells in organ donor eyes and restored communication between them as part of a series of discoveries that stand to transform brain and vision research.
none

Retinal cell map could advance precise therapies for blinding diseases

May 6, 2022

Researchers have identified distinct differences among the cells comprising a tissue in the retina that is vital to human visual perception. The scientists from the National Eye Institute (NEI) discovered five subpopulations of retinal pigment epithelium.